Search Results

You searched for : GileadSciences  

Corona curfew starts in Bhopal to counter recent surge in Covid-19 cases

The curfew has been enforced from April 12, 9 PM till April 19, 6 am...
Apr 13

Strides receives USFDA approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug, Truvada Tablets, 200 mg/300 mg, of Gilead Sciences...
Jan 15

Gilead and Galapagos announce new commercialization and development agreement for Jyseleca

Gilead and Galapagos will continue to investigate the potential for filgotinib to support patients living with Inflammatory Bowel Disease...
Dec 16

WHO drops Gilead's Remdesivir from Prequalification list

With Remdesivir out from benchmark drugs for Covid Gilead could be severely impacted...
Nov 21

WHO Guideline Development Group advises against use of remdesivir for covid-19

Currently no evidence that it improves survival and other important measures ...
Nov 20

ProteoNic announces licensing of its 2G UNic Technology Platform to Gilead Sciences

...
Nov 07

Knight Therapeutics signs a new distribution agreement with Gilead Sciences

The agreement will enter into force as of 1st January 2021...
Oct 27

Remdesivir useless for severe Covid-19 patients : WHO

The search for effective drug continues for severely affected Covid patients...
Oct 17

Saptagir Laboratories enters into exclusive agreement with Jubilant Generics

Another Indian company joins Remdesivir production...
Sep 15

Gilead Sciences and Jounce Therapeutics announce exclusive license agreement for novel immunotherapy program

Gilead Sciences, Inc. collaborates with Jounce Therapeutics, Inc., focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers...
Sep 02

Gilead Sciences and Tango Therapeutics to expand strategic oncology collaboration

The collaboration excludes Tango’s lead programs, including one program that is expected to be in investigational new drug (IND) applicatation-enabling studies next year...
Aug 19

Everest Organics announces Remdesivir API manufacturing

Now Everest Organics will also manufacture Ramdesivir API...
Aug 12

Gufic Lifesciences signs contract with Hetero Labs for Remdesivir lyophilised powder

Gufic Lifesciences has entered into a loan agreement with Hetero Labs Limited to manufacture and supply Remdesivir lyophilised powder ...
Aug 12

Jubilant Life Sciences Limited announces launch of ‘JUBI-R’ (remdesivir) in India

Now Jubiliant launches Remdesivir at Rs 4700...
Aug 04

Hetero to deliver 60,000 vials of Covifor

Hetero gears up to deliver Remdesivir doses in India...
Jul 16

Mylan Secures Regulatory Approval for Remdesivir in India

Mylan will manufacture remdesivir in India and would sell at Rs4,800 which is 80% less than the price in developed countries...
Jul 10

US buys entire global stock of COVID-19 drug Remdesivir from Gilead

US books all Remdesivir produced by Gilead Sciences leaving nothing for others...
Jul 02

Hetero launches Remdesivir generic, COVIFOR in India for the treatment of COVID-19

Hetero launches Remdesivir generic named Covifor for Indian markets ...
Jun 23

FDA warns against the usage of Remdesivir along with malaria antiviral Hydroxychloroquine

Remdesivir and HCQ is a deadly combination, reports US FDA...
Jun 17

HM allows of HCQ in early stages of Coronavirus ; Remdesivir for moderate cases

Health Ministry drops Azithromycin, suggest HCQ and Remdesivir instead for COVID patients...
Jun 15

Gilead Sciences collaborates with Indian Companies for Remdesivir

Under the licensing agreements, the companies have a right to receive a technology transfer of the Gilead Sciences manufacturing process for remdesivir to enable them ...
May 13

Cipla Signed an Agreement with Gilead for COVID-19 Treatment

Cipla Enters Into a Licensing Agreement With Gilead to Expand Access to COVID-19 Treatment ...
May 13

22 Matching result(s) found!

-Advertisements-



Trending Now

AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026
Dhiya Fertility and Maternity Center Performs Tamil Nadu’s First Robot-Assisted Fertility Procedure; 37-Year-Old Woman Delivers Healthy Baby GirlOctober 01, 2026
Habuild’s “Are You Still Awake?” Campaign Encourages India to Switch Off, Sleep on Time and Not Take Everything to Heart October 01, 2026
CoinSwitch Turns Profitable in FY26 as Revenue Surges 150% to ₹324 CrOctober 01, 2026
Mega CPR Training: Baby Memorial Hospital Vadakara enters Asia and India Book of RecordsOctober 01, 2026
Supertails vaccinates 300 dogs and cats against rabies across Bengaluru in a three-day World Rabies Day drive October 01, 2026
Why Continuity of Care Matters When Patients Move Between Health FacilitiesOctober 01, 2026
Building Stronger Referral Pathways Between Primary Care and Specialist ServicesOctober 01, 2026